Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction.

[1]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[2]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[3]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[4]  L. Kuller,et al.  Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. , 1994, American journal of epidemiology.

[5]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[6]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[7]  S. Shapiro,et al.  Decline in the risk of myocardial infarction among women who stop smoking. , 1990, The New England journal of medicine.

[8]  Salim Yusuf,et al.  Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. , 1990, The American journal of cardiology.

[9]  L Wilhelmsen,et al.  Risk factors for heart failure in the general population: the study of men born in 1913. , 1989, European heart journal.

[10]  P. Binkley,et al.  Hemodynamic effects of smoking in congestive heart failure. , 1988, The American journal of the medical sciences.

[11]  W. Kannel,et al.  Cardiac failure and sudden death in the Framingham Study. , 1988, American heart journal.

[12]  J. Murray,et al.  Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. , 1987, Circulation.

[13]  S. Shapiro,et al.  The risk of myocardial infarction after quitting smoking in men under 55 years of age. , 1985, The New England journal of medicine.

[14]  D. Shopland.  The Health consequences of smoking; cardiovascular disease : a report of the Surgeon General , 1983 .

[15]  W. Abelmann,et al.  Acute Hemodynamic Effects of Cigarette Smoking in Man Assessed by Systolic Time Intervals and Echocardiography , 1979, Circulation.

[16]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .